| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/18/2004 | WO2004022007A1 Composition and method for treating soft nails |
| 03/18/2004 | WO2004022002A2 Combined immediate release and extended release analgesic composition |
| 03/18/2004 | WO2004022001A2 Compositions and methods for inhibiting proliferation in human prostate cancer cells |
| 03/18/2004 | WO2004022000A2 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004021997A2 Inhibitors of fungal invasion |
| 03/18/2004 | WO2004021996A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 03/18/2004 | WO2004021995A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 03/18/2004 | WO2004021992A2 Delivery of therapeutics to the brain and spinal cord |
| 03/18/2004 | WO2004021990A2 Compositions and kits for the removal of irritating compounds from bodily surfaces |
| 03/18/2004 | WO2004021989A2 Imidazolopyridines and methods of making and using the same |
| 03/18/2004 | WO2004021988A2 Treatment of pain by inhibition of p38 map kinase |
| 03/18/2004 | WO2004021987A2 Treatment of rheumatoid arthritis by inhibition of pde4 |
| 03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/18/2004 | WO2004021983A2 In situ polymerizing medical compositions |
| 03/18/2004 | WO2004021978A2 Antisense modulation of endothelial specific molecule 1 expression |
| 03/18/2004 | WO2004021975A2 An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones |
| 03/18/2004 | WO2004021974A2 Non-psychotropic cannabinoids for prevention of cognitive impairment |
| 03/18/2004 | WO2004021973A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/18/2004 | WO2004021972A2 Pharmaceuticals formulations and methods for modified release of statin drugs |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2004021968A2 Solution for ungual application |
| 03/18/2004 | WO2004021967A2 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 03/18/2004 | WO2004021942A1 Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues |
| 03/18/2004 | WO2004021787A1 Ant spray containing d-limonene |
| 03/18/2004 | WO2004014289A3 Use of beta-cyclodextrin (cas rn: 7585-39-9) in the preparation of medicaments for the treatment of human and animal diseases caused by cryptosporidium parasites |
| 03/18/2004 | WO2004012733A3 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/18/2004 | WO2004012688A3 Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated cpg motifs |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 03/18/2004 | WO2004009543A3 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
| 03/18/2004 | WO2004007488A3 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004006885A3 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2004002482A3 2-pyridin acetic acid derivatives with antiproliferative activity |
| 03/18/2004 | WO2003106394A8 Preparations containing conjugated linoleic alcohol |
| 03/18/2004 | WO2003102116A3 Oil-soluble pigment compositions |
| 03/18/2004 | WO2003102012A9 New etonogestrel esters |
| 03/18/2004 | WO2003101403A8 Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome |
| 03/18/2004 | WO2003100009A3 Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | WO2003099289A3 Compositions and their uses for alleviating pain |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003099265A3 Pharmaceutical active substance combination and the use thereof |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003097025B1 A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom |
| 03/18/2004 | WO2003097008A3 Transdermal delivery device for the administration of fentanyl |
| 03/18/2004 | WO2003095421A8 Amino acid analogues |
| 03/18/2004 | WO2003094921A3 Utilization of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy |
| 03/18/2004 | WO2003094919A3 Novel crystalline forms of gatifloxacin |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003093290A3 Nucleoside derivatives for treating hepatitis c virus infection |
| 03/18/2004 | WO2003090744A8 Antibacterial compositions comprising metal phthalocyanine analogues |
| 03/18/2004 | WO2003086563A3 Diabetes imaging probes |
| 03/18/2004 | WO2003086442A3 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives |
| 03/18/2004 | WO2003086305A3 Biodegradable peg-based polymer formulations in ocular applications |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003082251A3 THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 α METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION |
| 03/18/2004 | WO2003079972A3 Active agent delivery systems and methods for protecting and administering active agents |
| 03/18/2004 | WO2003077885A3 Free-base formulations of local anesthetics |
| 03/18/2004 | WO2003075858A3 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/18/2004 | WO2003072734A3 Bipolar trans carotenoid salts and their uses |
| 03/18/2004 | WO2003072111A3 Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |
| 03/18/2004 | WO2003068147A3 Treatments for neurotoxicity in alzheimer’s disease |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003063788A3 PTPase INHIBITORS AND METHODS OF USING THE SAME |
| 03/18/2004 | WO2003059404A3 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 03/18/2004 | WO2003055446A9 Antifungal phenethylene |
| 03/18/2004 | WO2003047500A3 Vaccine and method for treatment of motor neurone diseases |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003044038A3 Biologically active complex |
| 03/18/2004 | WO2003043652A3 The use of leptin in fertility |
| 03/18/2004 | WO2003041701A3 Preparation for improving the action of receptors |
| 03/18/2004 | WO2003039435A3 Process of obtaining colloidal dispersions of amphotercin b; compounds based on amphothericine b for enteral, paraenteral and topical use; use of these compounds in the treatment of systemic mycoses and parasitic infections |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003035009A3 Treatment of acute myeloid leukemia with indolinone compounds |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003028623A3 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes |
| 03/18/2004 | WO2003026670A3 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 03/18/2004 | WO2003026563A3 Conjugated anti-psychotic drugs and uses thereof |
| 03/18/2004 | WO2003020698A3 Protein tyrosine kinase inhibitors |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | WO2003015809A3 Antimicrobial cationic peptides and formulations thereof |
| 03/18/2004 | WO2003015704A3 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002080856A3 Triaza compound immunoregulatory agents |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | WO2002064125A3 Use of a farnesoid x receptor antagonist for treating hyperlipidemia |
| 03/18/2004 | WO2002060867A3 Carbazole derivatives and their uses as heparanase inhibitors |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |